When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. A new type of bacteria was found in 50% of colon cancers ...

   www.aol.com/news/type-bacteria-found-50-colon...

   Colon cancer is the second-leading cause of cancer deaths in the United States and is expected to kill more than 53,000 people in the nation in 2024, according to the American Cancer Society.

3. You’re Not Too Young to Get Colon Cancer Anymore

   www.aol.com/not-too-young-colon-cancer-223600053...

   A new report from the American Cancer Society shows the rise in colorectal cancer among young people, especially men. What to look for, how to screen.

4. New colorectal cancer blood test approved by FDA: What to know

   www.aol.com/colorectal-cancer-blood-test...

   The Food and Drug Administration (FDA) has recently approved a blood test screening for colorectal cancer that has an over 83% success rate at detecting the presence of this form of cancer.

5. Colorectal cancer - Wikipedia

   en.wikipedia.org/wiki/Colorectal_cancer

   The treatment of colorectal cancer can be aimed at cure or palliation. The decision on which aim to adopt depends on various factors, including the person's health and preferences, as well as the stage of the tumor. [149] Assessment in multidisciplinary teams is a critical part of determining whether the patient is suitable for surgery or not ...

6. Cancer treatment - Wikipedia

   en.wikipedia.org/wiki/Cancer_treatment

   Cancer treatments are a wide range of treatments available for the many different types of cancer, with each cancer type needing its own specific treatment. [1] Treatments can include surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy including small-molecule drugs or monoclonal antibodies, [2] and PARP inhibitors such as olaparib. [3]

7. FOLFOX - Wikipedia

   en.wikipedia.org/wiki/FOLFOX

   Adjuvant treatment in patients with stage III colon cancer is recommended [2] for 12 cycles, every two weeks. The recommended dose schedule is as follows: Day 1: Oxaliplatin 85 mg/m 2 intravenous (IV) infusion in 250-500 mL D5W and leucovorin 200 mg/m 2 IV infusion in D5W administered concurrently over 120 minutes in separate bags using a Y-line, followed by fluorouracil (5-FU) 400 mg/m 2 IV ...